A single dose, blinded, balanced, randomised, two-treatment, two period, two sequence, two-way crossover pilot study comparing the pharmacokinetics of 1 x 8 mg atorvastatin oral spray (Medlab Clinical, Australia) with 1 x 20 mg Lipitor® capsule (Pfizer, Australia) in healthy subjects under fasting conditions.
NanoStatTM is an investigative new sub-micron spray delivering 8 mg Atorvastatin in four actuations of the pump applied to the oro-buccal membrane.
4 July 2017
Southern Health and Disability Ethics Committees, Wellington 6011 NZ
Zenith Technology Corp. Ltd - 156 Frederick Street, PO Box 1777, Dunedin, NZ